Display options
Cite
Zehra T, Siddique SK, Aamir R, et al. Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes. Cureus. 2021;13(3):e13720doi: 10.7759/cureus.13720.
Zehra, T., Siddique, S. K., Aamir, R., Mahmood, A., Kiani, A. H., & Virk, S. T. (2021). Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes. Cureus, 13(3), e13720. https://doi.org/10.7759/cureus.13720
Zehra, Tehzeeb, et al. "Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes." Cureus vol. 13,3 (2021): e13720. doi: https://doi.org/10.7759/cureus.13720
Zehra T, Siddique SK, Aamir R, Mahmood A, Kiani AH, Virk ST. Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes. Cureus. 2021 Mar 05;13(3):e13720. doi: 10.7759/cureus.13720. PMID: 33833931; PMCID: PMC8018858.
Copy Download .nbib Format: NLM
Share it on

Cureus. 2021 Mar 05;13(3):e13720. doi: 10.7759/cureus.13720.

Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes.

Cureus

Tehzeeb Zehra, Shahzad K Siddique, Rahila Aamir, Adil Mahmood, Abdul Hameed Kiani, Sana T Virk

Affiliations

  1. Internal Medicine, Shifa Tameer-E-Millat University, Shifa College of Medicine, Islamabad, PAK.
  2. Internal Medicine, Shifa International Hospital, Islamabad, PAK.
  3. Internal Medicine, Air University Islamabad, Islamabad, PAK.

PMID: 33833931 PMCID: PMC8018858 DOI: 10.7759/cureus.13720

Abstract

Background The medical community's understanding of the novel coronavirus disease (COVID-19) was limited initially, and many laboratory investigations were performed to observe effects of the virus on the body, its complications, and outcomes. We observed that some laboratory investigations provided redundant information regarding outcomes, and, therefore, were not necessary. Therefore, the extent of laboratory investigations may need to be pared down to not only avoid issues related to repeated blood sampling but also to minimize the financial burdens in poor socioeconomic countries.  Objective This study aimed to observe trends of clinical and laboratory values in COVID-19 patients and their relationship to outcomes, including disease severity, length of hospital stay, and mortality. Methods We conducted an observational cohort study of COVID-19 patients treated as inpatients at the Shifa International Hospital (SIH) in Islamabad in April 2020. Patients were included if they were nonsurgical, adult inpatients of SIH diagnosed with COVID-19 via positive polymerase chain reaction test. We monitored study participants' clinical and laboratory values (including hypoxia) on admission and throughout the study period. We used IBM SPSS Statistics for Windows, Version 23.0 (IBM Corp., Armonk, NY, USA) for data entry and analysis. Descriptive statistics were calculated for qualitative and quantitative data. We determined the effect of all variables on outcomes through chi-squared or Fisher's exact test, and p-values <0.05 with 95% confidence interval were considered statistically significant. Results A total of 51 patients with COVID-19 were enrolled. Most of the study participants were men older than age 50 with multiple comorbidities and resided in Khyber Pakhtunkhwa. Length of hospital stay ranged from eight to 14 days, and most patients had severe disease and survived. Factors such as patient age, gender, comorbid conditions, residence, and medication did not significantly affect outcomes. Hypotension during the height of symptoms and oxygen saturations <80% on admission was associated with prolonged hospital stays. Two complete blood count (CBC) parameters (platelet counts and mean corpuscular volume, MCV) were strongly associated with mortality and severity in our patients. Four non-CBC parameters (alanine transaminase, ALT; D-dimer; C-reactive protein, CRP; and lactate dehydrogenase, LDH) had strong statistical impact on disease severity, length of hospital stay, and mortality in our patients. Conclusion In a resource-limited country, laboratory testing must be chosen wisely and used appropriately. Patient age, gender, comorbid conditions, drugs, residence, and ferritin levels did not affect COVID-19 outcomes. Hemoglobin, platelet count, MCV, CRP, D-dimer, ALT, LDH, hypoxia, and hypotension were all correlated to disease outcomes. Therefore, these factors are useful laboratory examinations for COVID-19 patients, especially in poor countries.

Copyright © 2021, Zehra et al.

Keywords: covid-19; curtail laboratory testing in covid-19 patients; outcome predictors in covid-19; serial laboratory testing in covid -19; trends of laboratory values in covid-19

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. JAMA. 2020 Aug 25;324(8):782-793 - PubMed
  2. Ann Clin Microbiol Antimicrob. 2020 May 15;19(1):18 - PubMed
  3. Clin Chim Acta. 2020 Jul;506:145-148 - PubMed
  4. Clin Chem Lab Med. 2020 Jul 28;58(8):1171 - PubMed
  5. Diabetes Metab Syndr. 2020 May - Jun;14(3):241-246 - PubMed
  6. Am J Hematol. 2020 Aug;95(8):999-1000 - PubMed
  7. Hematol Transfus Cell Ther. 2020 Apr - Jun;42(2):116-117 - PubMed
  8. Int J Med Sci. 2020 Aug 19;17(14):2225-2231 - PubMed
  9. N Engl J Med. 2020 May 21;382(21):2012-2022 - PubMed
  10. J Clin Lab Anal. 2020 Oct;34(10):e23618 - PubMed
  11. JAMA. 2020 Mar 17;323(11):1061-1069 - PubMed
  12. Ann Transl Med. 2020 Oct;8(19):1230 - PubMed
  13. Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134 - PubMed
  14. J Autoimmun. 2020 Aug;112:102473 - PubMed
  15. Int J Lab Hematol. 2020 Dec;42(6):773-779 - PubMed
  16. Lancet. 2020 Feb 15;395(10223):497-506 - PubMed
  17. Infect Dis Poverty. 2020 Mar 17;9(1):29 - PubMed
  18. Virol J. 2015 Dec 22;12:221 - PubMed
  19. Respir Res. 2020 Jul 3;21(1):169 - PubMed
  20. Int Immunopharmacol. 2020 Jul;84:106504 - PubMed
  21. Lancet. 2020 Feb 15;395(10223):507-513 - PubMed
  22. Int J Infect Dis. 2020 Oct;99:47-56 - PubMed

Publication Types